BRPI0406172A - processo e dispositivo para a implantação minimamente invasiva de biomaterial - Google Patents

processo e dispositivo para a implantação minimamente invasiva de biomaterial

Info

Publication number
BRPI0406172A
BRPI0406172A BRPI0406172-1A BRPI0406172A BRPI0406172A BR PI0406172 A BRPI0406172 A BR PI0406172A BR PI0406172 A BRPI0406172 A BR PI0406172A BR PI0406172 A BRPI0406172 A BR PI0406172A
Authority
BR
Brazil
Prior art keywords
delivery device
minimally invasive
vascular tissue
lock
delivery
Prior art date
Application number
BRPI0406172-1A
Other languages
English (en)
Inventor
Lynetta Jean Freeman
Mark W Difrancesco
Original Assignee
Johnson & Johnson
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson & Johnson filed Critical Johnson & Johnson
Publication of BRPI0406172A publication Critical patent/BRPI0406172A/pt
Publication of BRPI0406172B1 publication Critical patent/BRPI0406172B1/pt
Publication of BRPI0406172B8 publication Critical patent/BRPI0406172B8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/148—Materials at least partially resorbable by the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/16—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/18—Materials at least partially X-ray or laser opaque
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Surgery (AREA)
  • Vascular Medicine (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Chemical & Material Sciences (AREA)
  • Optics & Photonics (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Medicinal Preparation (AREA)
  • Media Introduction/Drainage Providing Device (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Surgical Instruments (AREA)
  • Materials For Medical Uses (AREA)

Abstract

"PROCESSO E DISPOSITIVO PARA A IMPLANTAçãO MINIMAMENTE INVASIVA DE BIOMATERIAL". São revelados um processo minimamente invasivo de colocar um dispositivo de entrega substancialmente adjacente a tecido vascular e um dispositivo para utilização com um tal processo. O dispositivo de entrega pode ser uma construção biológica flexível com um travamento flexível. O dispositivo de entrega pode ser inserido percutaneamente próximo de tecido vascular tal como, por exemplo, tecido peritoneal. Quando tiver sido inserido o dispositivo de entrega, a trava pode ser utilizada para puxar o dispositivo de entrega contra o tecido vascular e fixar o dispositivo ao mesmo. O contato entre a superfície dianteira do dispositivo de entrega e o tecido vascular pode ser mantido tornando e mantendo a trava substancialmente esticada. O dispositivo de entrega pode servir para realizar entrega sustentada de agentes ativos.
BRPI0406172A 2003-12-15 2004-12-15 dispositivo de entrega de agente ativo minimamente invasiva de biomaterial BRPI0406172B8 (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10/736,421 US7780973B2 (en) 2003-12-15 2003-12-15 Method and device for minimally invasive implantation of biomaterial

Publications (3)

Publication Number Publication Date
BRPI0406172A true BRPI0406172A (pt) 2006-03-28
BRPI0406172B1 BRPI0406172B1 (pt) 2018-10-09
BRPI0406172B8 BRPI0406172B8 (pt) 2021-06-22

Family

ID=34523123

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0406172A BRPI0406172B8 (pt) 2003-12-15 2004-12-15 dispositivo de entrega de agente ativo minimamente invasiva de biomaterial

Country Status (8)

Country Link
US (1) US7780973B2 (pt)
EP (1) EP1543851B1 (pt)
JP (1) JP4959130B2 (pt)
CN (1) CN1788688A (pt)
AU (1) AU2004235619A1 (pt)
BR (1) BRPI0406172B8 (pt)
CA (1) CA2489735C (pt)
PL (1) PL1543851T3 (pt)

Families Citing this family (75)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7731947B2 (en) 2003-11-17 2010-06-08 Intarcia Therapeutics, Inc. Composition and dosage form comprising an interferon particle formulation and suspending vehicle
US8728132B2 (en) * 2004-04-20 2014-05-20 James L. Chappuis Internal pedicle insulator apparatus and method of use
US20050267556A1 (en) * 2004-05-28 2005-12-01 Allan Shuros Drug eluting implants to prevent cardiac apoptosis
US20090216115A1 (en) * 2004-07-23 2009-08-27 Calypso Medical Technologies, Inc. Anchoring wirless markers within a human body
WO2006083761A2 (en) 2005-02-03 2006-08-10 Alza Corporation Solvent/polymer solutions as suspension vehicles
US11246913B2 (en) 2005-02-03 2022-02-15 Intarcia Therapeutics, Inc. Suspension formulation comprising an insulinotropic peptide
US9060820B2 (en) 2005-05-18 2015-06-23 Sonoma Orthopedic Products, Inc. Segmented intramedullary fracture fixation devices and methods
US8961516B2 (en) 2005-05-18 2015-02-24 Sonoma Orthopedic Products, Inc. Straight intramedullary fracture fixation devices and methods
US20070048288A1 (en) * 2005-08-30 2007-03-01 Lyu Suping Shear thinning polymer cell delivery compositions
WO2007061890A2 (en) 2005-11-17 2007-05-31 Calypso Medical Technologies, Inc. Apparatus and methods for using an electromagnetic transponder in orthopedic procedures
US8278094B2 (en) 2005-12-14 2012-10-02 The Invention Science Fund I, Llc Bone semi-permeable device
US8682619B2 (en) * 2005-12-14 2014-03-25 The Invention Science Fund I, Llc Device including altered microorganisms, and methods and systems of use
US8734823B2 (en) * 2005-12-14 2014-05-27 The Invention Science Fund I, Llc Device including altered microorganisms, and methods and systems of use
US8357114B2 (en) 2006-01-06 2013-01-22 Acelrx Pharmaceuticals, Inc. Drug dispensing device with flexible push rod
US8865743B2 (en) 2006-01-06 2014-10-21 Acelrx Pharmaceuticals, Inc. Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
US8753308B2 (en) 2006-01-06 2014-06-17 Acelrx Pharmaceuticals, Inc. Methods for administering small volume oral transmucosal dosage forms using a dispensing device
US9066847B2 (en) 2007-01-05 2015-06-30 Aceirx Pharmaceuticals, Inc. Storage and dispensing devices for administration of oral transmucosal dosage forms
US9289583B2 (en) * 2006-01-06 2016-03-22 Acelrx Pharmaceuticals, Inc. Methods for administering small volume oral transmucosal dosage forms using a dispensing device
US8202535B2 (en) 2006-01-06 2012-06-19 Acelrx Pharmaceuticals, Inc. Small-volume oral transmucosal dosage forms
US8252329B2 (en) 2007-01-05 2012-08-28 Acelrx Pharmaceuticals, Inc. Bioadhesive drug formulations for oral transmucosal delivery
KR101106510B1 (ko) 2006-05-30 2012-01-20 인타르시아 세라퓨틱스 인코포레이티드 투피스, 내부채널 삼투압 전달 시스템 유동 조절기
US9669198B2 (en) * 2006-07-27 2017-06-06 University Of Virginia Patent Foundation System and method for intracranial implantation of therapeutic or diagnostic agents
CA2670821C (en) * 2006-08-09 2012-05-15 Intarcia Therapeutics, Inc. Osmotic delivery systems and piston assemblies
CA2670263A1 (en) 2006-11-22 2008-05-29 Sonoma Orthopedic Products, Inc. Fracture fixation device, tools and methods
CA2683610C (en) 2007-04-23 2013-01-08 Intarcia Therapeutics, Inc. Suspension formulations of insulinotropic peptides and uses thereof
WO2009042768A1 (en) * 2007-09-25 2009-04-02 University Of Pittsburgh-Of The Commonwealth System Of Higher Education Triggerably dissolvable hollow fibers for controlled delivery
US8457757B2 (en) 2007-11-26 2013-06-04 Micro Transponder, Inc. Implantable transponder systems and methods
US9089707B2 (en) 2008-07-02 2015-07-28 The Board Of Regents, The University Of Texas System Systems, methods and devices for paired plasticity
WO2009102467A2 (en) 2008-02-13 2009-08-20 Intarcia Therapeutics, Inc. Devices, formulations, and methods for delivery of multiple beneficial agents
CA2724327A1 (en) 2008-06-04 2009-12-10 Neovista, Inc. Handheld radiation delivery system for advancing a radiation source wire
AU2009296243A1 (en) 2008-09-26 2010-04-01 Sonoma Orthopedic Products, Inc. Bone fixation device, tools and methods
WO2010053737A1 (en) * 2008-10-29 2010-05-14 Wilson-Cook Medical, Inc. Endoscopic sheet delivery
EP2352544A4 (en) * 2008-11-07 2013-12-25 Combinent Biomedical Systems Inc DEVICES AND METHOD FOR THE TREATMENT AND / OR PREVENTION OF DISEASES
EP2384147B1 (en) * 2008-12-11 2014-08-13 Cook Medical Technologies LLC Endoscopic sheet rolling system
US9943704B1 (en) 2009-01-21 2018-04-17 Varian Medical Systems, Inc. Method and system for fiducials contained in removable device for radiation therapy
US8548623B2 (en) * 2009-03-18 2013-10-01 Acelrx Pharmaceuticals, Inc. Storage and dispensing devices for administration of oral transmucosal dosage forms
US8647311B2 (en) * 2009-09-21 2014-02-11 Translational Biologic Infusion Catheter, Llc Biologics infusion system
US10155099B2 (en) 2009-09-21 2018-12-18 Cook Regentec Llc Method for infusing stem cells
MX378797B (es) 2009-09-28 2025-03-10 Intarcia Therapeutics Inc Establecimiento y/o terminacion rapidos de suministro de estado estable sustancial de farmaco.
WO2011068866A1 (en) * 2009-12-04 2011-06-09 Novalign Orthepaedics, Inc. Device and method for tensioning an elongate member
DE102010013898A1 (de) * 2010-04-01 2011-10-06 Acino Ag Implantatskanüle mit Implantat und Verfahren zum Befestigen von Implantaten in einer Injektionskanüle
US8876761B2 (en) 2010-05-26 2014-11-04 Ethicon Endo-Surgery, Inc. Intestinal brake inducing intraluminal therapeutic substance eluting devices and methods
US20110295179A1 (en) 2010-05-26 2011-12-01 Harris Jason L Methods and devices for regulating the activation of ghrelin hormones within a stomach
US20110295178A1 (en) 2010-05-26 2011-12-01 Albrecht Thomas E Intestinal Brake Inducing Intraluminal Therapeutic Substance Eluting Devices and Methods
US20110295151A1 (en) 2010-05-26 2011-12-01 Bakos Gregory J Enteroendocrine Manipulation for Metabolic Effect
US20120208755A1 (en) 2011-02-16 2012-08-16 Intarcia Therapeutics, Inc. Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
ES2817789T3 (es) 2012-11-12 2021-04-08 Hollister Inc Conjunto de catéter intermitente
EP2919825B1 (en) 2012-11-14 2018-10-17 Hollister Incorporated Disposable catheter with selectively degradable inner core
DK3862031T3 (da) 2013-11-08 2023-09-25 Hollister Inc Smurte, oleofile katetre
AU2014363933B2 (en) 2013-12-12 2019-10-10 Hollister Incorporated Flushable disintegration catheter
HUE049637T2 (hu) 2013-12-12 2020-09-28 Hollister Inc Toalettben lehúzható katéterek
LT3079749T (lt) 2013-12-12 2019-12-27 Hollister Incorporated Srove nuplaunami kateteriai
LT3079750T (lt) 2013-12-12 2020-07-27 Hollister Incorporated Srove nuplaunami kateteriai
US9770278B2 (en) 2014-01-17 2017-09-26 Arthrex, Inc. Dual tip guide wire
US9889085B1 (en) 2014-09-30 2018-02-13 Intarcia Therapeutics, Inc. Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
US9814499B2 (en) 2014-09-30 2017-11-14 Arthrex, Inc. Intramedullary fracture fixation devices and methods
US11058856B2 (en) 2014-12-23 2021-07-13 Acelrx Pharmaceuticals, Inc. Systems, devices and methods for dispensing oral transmucosal dosage forms
WO2016191302A1 (en) * 2015-05-22 2016-12-01 Dexcom, Inc. Needle for transcutaneous analyte sensor delivery
CN113598842A (zh) 2015-06-03 2021-11-05 因塔西亚制药公司 植入物放置和移除系统
LT3310404T (lt) 2015-06-17 2024-04-10 Hollister Incorporated Selektyviai vandenyje tirpstančios medžiagos ir iš tokių medžiagų kateteriai
PT3682915T (pt) 2015-10-30 2023-06-26 Acelrx Pharmaceuticals Inc Aparelho e métodos para dispensar formas de dosagem trasnmucosa oral
CN108778171A (zh) * 2016-01-15 2018-11-09 Tva医疗公司 用于粘附血管的系统和方法
KR102574993B1 (ko) 2016-05-16 2023-09-06 인타르시아 세라퓨틱스 인코포레이티드 글루카곤-수용체 선택적 폴리펩티드 및 이들의 이용 방법
USD860451S1 (en) 2016-06-02 2019-09-17 Intarcia Therapeutics, Inc. Implant removal tool
USD840030S1 (en) 2016-06-02 2019-02-05 Intarcia Therapeutics, Inc. Implant placement guide
US11707611B2 (en) 2016-11-08 2023-07-25 W. L. Gore & Associates, Inc. Implantable apparatus for retention of biological moieties
WO2018129058A1 (en) 2017-01-03 2018-07-12 Intarcia Therapeutics, Inc. Methods comprising continuous administration of a glp-1 receptor agonist and co-adminstration of a drug
GB2583231B (en) * 2017-11-14 2023-07-19 Cook Biotech Inc Sterilized tissue products and related methods
JP2021502814A (ja) 2017-11-14 2021-02-04 クック・バイオテック・インコーポレイテッドＣｏｏｋ Ｂｉｏｔｅｃｈ Ｉｎｃｏｒｐｏｒａｔｅｄ 保存組織製品および関連する方法
EP3545897A1 (en) * 2018-03-29 2019-10-02 Koninklijke Philips N.V. An implantable device
USD933219S1 (en) 2018-07-13 2021-10-12 Intarcia Therapeutics, Inc. Implant removal tool and assembly
KR102201828B1 (ko) 2020-02-24 2021-01-26 (주)서한케어 정위가이드기구
WO2022067046A1 (en) * 2020-09-24 2022-03-31 University Of Cincinnati Continuous optical aptamer sensors
DE102020129916A1 (de) 2020-11-12 2022-05-12 Lts Lohmann Therapie-Systeme Ag. Interdermales Wirkstoffabgabesystem
JP7811121B2 (ja) * 2022-02-28 2026-02-04 テルモ株式会社 下肢に留置する細胞留置デバイス

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4987136A (en) 1982-03-16 1991-01-22 The Rockefeller University Method for controlling gastrointestinal dysmotility
GB2145443B (en) * 1983-07-21 1986-07-23 Ethicon Inc Improvements in fibrous structures
US4902295A (en) 1985-08-26 1990-02-20 Hana Biologics, Inc. Transplantable artificial tissue
US5604293A (en) 1985-09-12 1997-02-18 Scios Inc. Recombinant human basic fibroblast growth factor
US5487739A (en) 1987-11-17 1996-01-30 Brown University Research Foundation Implantable therapy systems and methods
US5674722A (en) 1987-12-11 1997-10-07 Somatix Therapy Corporation Genetic modification of endothelial cells
US6007840A (en) 1988-09-16 1999-12-28 Novartis Ag Pharmaceutical compositions comprising cyclosporins
US5254133A (en) 1991-04-24 1993-10-19 Seid Arnold S Surgical implantation device and related method of use
SG47470A1 (en) * 1991-04-25 1998-04-17 Univ Brown Res Found Implantable biocompatible immunoisolatory vehicle for delivery of a selected therapeutic products
US5604294A (en) 1991-09-05 1997-02-18 Luly; Jay R. Macrocyclic immunomodulators
WO1994021254A1 (en) 1993-03-17 1994-09-29 Abbott Laboratories Substituted alicyclic amine-containing macrocyclic immunomodulators
EP0692971A4 (en) 1993-03-29 1997-11-12 Univ Cincinnati PEPTID YY ANALOGS AND USES THEREFOR
JPH09501162A (ja) 1993-07-30 1997-02-04 アボツト・ラボラトリーズ 免疫調節活性を有する活性化マクロラクタム
US5612350A (en) 1993-11-30 1997-03-18 Abbott Laboratories Macrocyclic immunomodulators with novel cyclohexyl ring replacements
PT734389E (pt) 1993-12-17 2000-09-29 Novartis Ag Derivados de rapamicina uteis como imunossupressores
US5531759A (en) 1994-04-29 1996-07-02 Kensey Nash Corporation System for closing a percutaneous puncture formed by a trocar to prevent tissue at the puncture from herniating
US5912227A (en) 1995-01-27 1999-06-15 North Carolina State University Method of enhancing nutrient uptake
AR004480A1 (es) 1995-04-06 1998-12-16 Amico Derin C D Compuestos de ascomicina que poseen actividad antiinflamatoria, pro cedimiento para prepararlos, uso de dichos compuestos para preparar agentesfarmaceuticos y composiciones farmaceuticas que los incluyen
US5859031A (en) 1995-06-07 1999-01-12 Gpi Nil Holdings, Inc. Small molecule inhibitors of rotamase enzyme activity
FR2736550B1 (fr) 1995-07-14 1998-07-24 Sandoz Sa Composition pharmaceutique sous la forme d'une dispersion solide comprenant un macrolide et un vehicule
US6171298B1 (en) 1996-05-03 2001-01-09 Situs Corporation Intravesical infuser
IT1283102B1 (it) 1996-06-06 1998-04-07 Permatec Nv Composizione terapeutica per la somministrazione transdermica di un principio attivo estrogeno o progestinico o di loro miscele
CA2263890C (en) 1996-08-23 2013-05-14 Ludwig Institute For Cancer Research Recombinant vascular endothelial cell growth factor d (vegf-d)
US5786378A (en) 1996-09-25 1998-07-28 Gpi Nil Holdings, Inc. Heterocyclic thioesters
FR2757521B1 (fr) 1996-12-24 1999-01-29 Rhone Poulenc Rorer Sa Nouveaux derives de cyclosporine, leur preparation et les compositions pharmaceutiques qui les contiennent
US6406498B1 (en) 1998-09-04 2002-06-18 Bionx Implants Oy Bioactive, bioabsorbable surgical composite material
US6638727B1 (en) 1999-01-26 2003-10-28 Cytyc Health Corporation Methods for identifying treating or monitoring asymptomatic patients for risk reduction or therapeutic treatment of breast cancer
GB0307082D0 (en) 2003-03-27 2003-04-30 Gyne Ideas Ltd Drug delivery device and method

Also Published As

Publication number Publication date
CA2489735C (en) 2014-02-11
US20050131386A1 (en) 2005-06-16
JP2005194272A (ja) 2005-07-21
CN1788688A (zh) 2006-06-21
PL1543851T3 (pl) 2014-09-30
JP4959130B2 (ja) 2012-06-20
BRPI0406172B1 (pt) 2018-10-09
CA2489735A1 (en) 2005-06-15
AU2004235619A1 (en) 2005-06-30
EP1543851B1 (en) 2014-04-23
US7780973B2 (en) 2010-08-24
BRPI0406172B8 (pt) 2021-06-22
EP1543851A1 (en) 2005-06-22

Similar Documents

Publication Publication Date Title
BRPI0406172B8 (pt) dispositivo de entrega de agente ativo minimamente invasiva de biomaterial
ES2570599T3 (es) Composición suave para desinfección cutánea
ATE402002T1 (de) Elektroverarbeitetes kollagen
PE20020397A1 (es) Composicion a base de minoxidil
BR0111645A (pt) Tratamento de superfìcie de dispositivo médico
WO2006121518A3 (en) Electrical devices, anti-scarring agents, and therapeutic compositions
BRPI0410497A (pt) dispositivo e método de limpeza para limpar instrumento médico
BR0108452A (pt) Inibidores da oxidação parcial de ácido graxo no tratamento de insuficiência cardìaca congestiva
IL156766A0 (en) Procedure and composition of treatment and/or care of the eye
EP2175834B8 (en) Glp-1-fc fusion protein formulation
YU48099A (sh) Kompozicija koja obuhvata hranljivi materijal i biljku i njena upotreba
WO2008083097A3 (en) Steerable ablation device
IL158120A0 (en) High strength bioresorbables containing poly-glycolic acid
AU2003260353A1 (en) Device for the surgical treatment of female prolapse
MXPA03001118A (es) Estuche quirurgico para procedimientos de gastrostomia endoscopica percutanea de tipo de "jalado".
AR043985A1 (es) Tratamiento terapeutico de la constipacion
CO5251434A1 (es) Composicion de liberacion controlada
WO2004004757A8 (en) Treatment for eye disorder
YU75403A (sh) Vodeni amfotericin b preparat
WO2004054558A3 (en) Reduction of breast density with 4-hydroxy tamoxifen
CA2578031A1 (en) Compositions containing trialkanolamine alkoxylate buffer
AU2002317501A1 (en) Antiobestic and/or antidiabetic agent containing cyanidin 3-glucoside as active ingredient
BR0304298A (pt) Composição contendo um ácido orgânico cosmeticamente ativo e um produto de legume
WO2003099230A3 (en) Electroprocessed collagen and tissue engineering
CN109303705A (zh) 一种酒精消毒湿巾

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: AS CLASSIFICACOES ANTERIORES ERAM: A61K 9/70 , A61L 31/14 , A61L 31/16 , A61M 31/00

Ipc: A61L 31/14 (2006.01), A61L 31/16 (2006.01), A61M 3

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 09/10/2018, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 15/12/2004, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF, QUE DETERMINA A ALTERACAO DO PRAZO DE CONCESSAO

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 17A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2649 DE 13-10-2021 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.